Cn /En

News Center

——

Company news

Industry news

Functionality of the 3D organoid platform of InnoModels Biotechnology

Author:

InnoModels

Release time:

2024-08-09

In the fast-changing world of biotechnology, InnoModels Biotechnology (Beijing) Co., Ltd. has brought breakthroughs in the fields of new drug discovery, disease modeling and personalized medicine with its innovative 3D organoid platform. Based on the clinical tumor biosample library, the platform realizes the seamless integration of the whole process from in vitro high-throughput screening to in vivo research through advanced technological means, providing strong support for researchers.
Rapid Prediction and Drug Screening
A core function of the 3D organoid platform of InnoModels Biotechnology is the rapid prediction of drug efficacy in the clinic. This feature enables researchers to obtain critical feedback in the early stages of drug development so that they can make timely adjustments to their R&D strategies. In addition, the platform is able to screen compounds with higher development potential from a wide range of alternatives, greatly optimizing resource allocation and accelerating the process of new drug development.
Model Screening and Efficacy Comparison
On the basis of drug screening, the platform can also select the most suitable model for subsequent in vivo experiments based on the response of the drug to the model. This feature ensures the consistency and reliability of experimental data, providing researchers with more accurate experimental results. At the same time, by comparing with counterpart drugs or clinical therapeutic drugs, the platform can intuitively demonstrate the differences in efficacy and effective models, providing a strong basis for further optimization of drugs.
Disease specificity analysis and drug resistance analysis
For different types of cancers, the 3D organoid platform from InnoModels Biotechnology is able to compare the efficacy differences between different cancer model cohorts to determine the best indication for a drug. This feature is important for improving drug targeting and effectiveness. In addition, the platform is able to differentiate models into effective and resistant models based on efficacy data, and based on the differences in genetic features between models and before and after treatment, it can deeply explore the mechanism of action and resistance of drugs to provide more scientific guidance for clinical drug use.

Biomarker Discovery
The 3D organoid platform of InnoModels also has the function of biomarker discovery. By categorizing models according to their efficacy and analyzing the differences in genetic characteristics of different groups based on histology, researchers can find biomarkers that can predict drug efficacy. These biomarkers not only help in the precise treatment of drugs, but also provide an important reference for the early diagnosis and prognosis assessment of diseases.
Advantages of 3D organoid technology
The 3D organoid platform of InnoModels Biotechnology has such powerful functions thanks to its 3D organoid technology. Compared with traditional 2D cell culture and animal experiments, 3D organoids can better simulate the natural physiological processes of cells, providing more accurate models of human disease development and more clinically valuable research results. In addition, 3D organoids have realistic microanatomical structures and organ-specific cell types, and can even mimic part of an organ's function, making the research results closer to the real situation.
Summarization
In summary, the 3D organoid platform of InnoModels Biotechnology has shown great potential and value in the field of biotechnology by virtue of its powerful functions such as rapid prediction, drug screening, model screening, efficacy comparison, disease specificity analysis, drug resistance analysis, and biomarker discovery. The platform not only accelerates the process of new drug development and improves the targeting and effectiveness of drugs, but also provides powerful support for early diagnosis, prognosis assessment and personalized treatment of diseases. In the future, with the continuous progress and improvement of the technology, the 3D organoid platform will certainly play an even more important role in the field of biotechnology.

Introduction to the InnoModels Biotechnology Bowel Disease (IBD) Modeling Platform

Introduction to the Gouty Arthritis (GA) model of InnoModels Biotechnology

Introduction to the InnoModels Biotechnology Bowel Disease (IBD) Modeling Platform

Introduction to the Gouty Arthritis (GA) model of InnoModels Biotechnology

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License